- £112.48m
- £121.71m
- £85.75m
- 78
- 50
- 77
- 81
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 78.2 | 73 | 81.1 | 83.6 | 85.8 |
Cost of Revenue | |||||
Gross Profit | 39.2 | 38.6 | 41.8 | 31.3 | 42.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 80.7 | 63.8 | 72.3 | 82.8 | 78.5 |
Operating Profit | -2.45 | 9.11 | 8.89 | 0.779 | 7.26 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.89 | 8.51 | 8.61 | 0.387 | 6.63 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.96 | 6.36 | 6.99 | -0.51 | 5.29 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.96 | 6.36 | 6.99 | -0.51 | 5.29 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.96 | 6.36 | 6.99 | -0.51 | 5.29 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.054 | 0.035 | 0.047 | 0.017 | 0.037 |
Dividends per Share |